Advertisement
Sino Biological
Sino Biological

The Scientist

» science funding, immunology and culture

Most Recent

image: Let Them Eat Dirt

Let Them Eat Dirt

By | March 22, 2012

Early exposure to microbes shapes the mammalian immune system by subduing inflammatory T cells.

28 Comments

image: Pharma Puts Up Money for Biotech

Pharma Puts Up Money for Biotech

By | March 21, 2012

GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.

0 Comments

image: Immune Role in Brain Disorder?

Immune Role in Brain Disorder?

By | March 19, 2012

Replacing immune cells in a mouse model of Rett syndrome, a developmental brain disorder, improved symptoms, suggesting a new target for treatment.

2 Comments

image: Slipping from the Top?

Slipping from the Top?

By | March 14, 2012

Experts and the American public worry that the country is at risk of losing its global leadership position in scientific research.

24 Comments

image: Research is Tough for Dads Too

Research is Tough for Dads Too

By | March 12, 2012

A new survey finds that men as well as women scientists struggle to find time for family and life outside of the lab.

6 Comments

image: Transplant Without Drugs?

Transplant Without Drugs?

By | March 8, 2012

A new method for transplanting immunologically mismatched organs may remove the need for life-long immunosuppressive drugs to prevent rejection.

6 Comments

image: The Sweet Sounds of Spider Silk

The Sweet Sounds of Spider Silk

By | March 7, 2012

A researcher spins spider silk into violin strings.

4 Comments

image: Opinion: A Big Pharma Biotech Fund

Opinion: A Big Pharma Biotech Fund

By | March 5, 2012

Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.

4 Comments

In Chapter 8, "The Conspiratorial Move and the Struggle for Evidence-Based Medicine," author Nicoli Natrass explores the Internet's role in the rise of anti-science sentiment.

12 Comments

image: Braving the IPO Drought

Braving the IPO Drought

By | March 1, 2012

Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Addgene
Addgene
Advertisement
Life Technologies